Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Laval University
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age of 18 and over
Stage 3 or 4 chronic kidney disease (modified MDRD)
proteinuria of \> 1g/d on ACEi and/or ARB, or proteinuria of \> 1g/d with intolerance or contraindication to ACEi and/or ARB
blood pressure \< 130/80 mmHg or \< 140/90 mmHg in patients with five or more antihypertensive drugs
stable renal function
You may not be if
rapid progression of renal failure
immunosuppressive therapy within the past 3 months
need a renal replacement therapy within 8 months
definite history of chronic liver disease, or abnormal liver function
evidence of active inflammatory muscle disease
definite previous adverse reaction to a statin
concurrent treatment with a contraindicated drug (fibrate, macrolide antibiotic, systemic use of imidazole or triazole antifungals, protease-inhibitors, ciclosporin)
child bearing potential
known to be poorly compliant with clinic visits or prescribed medication
Clareo Health | Study of Atorvastatin Dose Dependent Reduction of Proteinuria
